ライフサイエンスコーパス: lymphoid enhancer factor

1 nal activity by competing with T-cell factor/lymphoid enhancer factor.

2 Lymphoid enhancer factor 1 (LEF-1) and T cell factor 1 (

3 Lymphoid Enhancer Factor 1 (Lef-1) is an important devel

4 The transcription factor lymphoid enhancer factor 1 (LEF-1) is directed to the nu

5 Lymphoid enhancer factor 1 (LEF-1) mediates Wnt signalin

6 Regulation of the lymphoid enhancer factor 1 (Lef-1) transcription factor

7 ate the transcriptional activities of STAT1, lymphoid enhancer factor 1 (LEF-1), and the androgen rec

8 A FLS by transfection with dominant-negative lymphoid enhancer factor 1 (LEF-1)/T cell factor 4 (TCF-

9 ssociation with transcription factors of the lymphoid enhancer factor 1 (LEF-1)/T-cell factor (TCF) f

10 Contrasting examples are provided by SRY and lymphoid enhancer factor 1 (LEF-1): whereas the SRY tail

11 unique function for the transcription factor lymphoid enhancer factor 1 (LEF1) in the postselection e

12 that expression of the transcription factor lymphoid enhancer factor 1 (Lef1) is Notch dependent in

13 that the movo1 promoter is activated by the lymphoid enhancer factor 1 (LEF1)/beta-catenin complex,

14 beta-catenin and transcription activation of lymphoid enhancer factor 1 (LEF1)/T-cell factor (TCF) ta

15 ocket protein inhibitory complex, as well as lymphoid enhancer factor 1 and Pitx2, by dismissal of hi

16 omplex, which interacts with T-cell factor 4/lymphoid enhancer factor 1 transcription factors and act

17 n inhibits Wnt-1 stimulation of beta-catenin/lymphoid enhancer factor 1-dependent transcription.

18 d the interaction of beta-catenin and T cell/lymphoid enhancer factor 1.

19 The lymphoid enhancer factor 1/T cell factor (LEF/TCF) famil

20 lity group (HMG) DNA binding domain of human lymphoid enhancer factor-1 (hLEF-1) as bait in a yeast t

21 ole in regulating beta-catenin/T Cell Factor/Lymphoid Enhancer Factor-1 (LEF) signaling.

22 on of beta-catenin, which interacts with the lymphoid enhancer factor-1 (LEF)/T-cell factor (TCF) fam

23 Lymphoid Enhancer Factor-1 (LEF-1) is a member of a fami

24 d the ability of each Axin mutant to inhibit lymphoid enhancer factor-1 (Lef-1) reporter activity in

25 tion of beta-catenin and T cell factor (TCF)/lymphoid enhancer factor-1 (LEF-1), a transcriptional fa

26 s (-199 C to A) within a potential motif for lymphoid enhancer factor-1 (LEF-1), a transcriptional me

27 T cell factor-1 (TCF-1) and lymphoid enhancer factor-1 (LEF-1), members of the TCF/L

28 Transcription of the lymphoid enhancer factor-1 (LEF1) gene is aberrantly act

29 catenin induced the binding of T-cell factor/lymphoid enhancer factor-1 to these sites, promoted the

30 of the beta-catenin-dependent T-cell factor.lymphoid enhancer factor-1 transactivation and invasiven

31 yposis coli, GSK3beta, axin 1, beta-catenin, lymphoid enhancer factor-1, cyclin D1, and c-myc, reveal

32 dent on the cyclin D1 promoter T-cell factor/lymphoid enhancer factor-1-binding site between -81 to -

33 n-dependent transactivation of T-cell factor.lymphoid enhancer factor-1.

34 of the sequence-specific HMG domain protein, lymphoid enhancer factor-1.

35 gher cytosolic beta-catenin and beta-catenin/lymphoid enhancer factor-1/T cell factor (beta-catenin/L

36 cleus, where it cooperates with LEF/TCF (for lymphoid enhancer factor and T-cell factor) transcriptio

37 ggest that HRG regulate Tiam1 activation and lymphoid enhancer factor/beta-catenin nuclear signaling

38 ain a single, highly conserved T-cell factor/lymphoid enhancer factor binding site that is required f

39 ts Wnt signaling, beta-catenin/T-cell factor/lymphoid-enhancer factor-dependent transcription and cel

40 y of Dvl3 to activate TCF/LEF (T-cell factor/lymphoid enhancer factor)-driven transcription and induc

41 ed to the nucleus, binds to T cell factor or lymphoid enhancer factor family members, and transactiva

42 us secondary axis and TCF/LEF (T Cell factor/lymphoid enhancer factor family) reporter assays, we dem

43 nd induces dissociation of beta-catenin from lymphoid enhancer factor in retinoid-free cultures.

44 ioned, chromatin-bound T-cell factor (Tcf) 1/lymphoid enhancer factor (Lef) 1 to facilitate recruitme

45 ted nuclear beta-catenin/T-cell factor (Tcf)-lymphoid enhancer factor (LEF) complex formation have be

46 Sox9 and T-cell factor (TCF) x lymphoid enhancer factor (LEF) factors contain HMG domai

47 Sox17 and Sox4 physically interact with TCF/lymphoid enhancer factor (LEF) family members via their

48 by beta-catenin and the T-cell factor (TCF)-lymphoid enhancer factor (LEF) family transcription fact

49 sient transfections with T cell factor (TCF)/lymphoid enhancer factor (LEF) optimized promoter report

50 ctivate the beta-catenin/T-cell factor (TCF)/lymphoid enhancer factor (LEF) signaling pathway.

51 scription factors of the T-cell Factor (Tcf)/Lymphoid Enhancer Factor (LEF) subfamily and mediates di

52 pathway, which activates T-cell factor (TCF)/lymphoid enhancer factor (LEF) transcription and is ofte

53 ation of beta-catenin, and activation of the lymphoid enhancer factor (LEF) transcription factor.

54 hrough the activation of T-cell factor (TCF)/lymphoid enhancer factor (LEF) transcription factors.

55 its interaction with T cell factor (TCF) or lymphoid enhancer factor (Lef) transcription factors.

56 expression causing formation of beta-catenin-lymphoid enhancer factor (LEF)-1 complexes that initiate

57 to Galpha(q), activates T-cell factor (Tcf)/lymphoid enhancer factor (Lef)-mediated transcriptional

58 r Ras, Neu, and Src, and by the beta-catenin/lymphoid enhancer factor (LEF)/T cell factor (TCF) pathw

59 LEF1 is a member of the lymphoid enhancer factor (LEF)/T-cell factor family of D

60 Dlx2, Lymphoid Enhancer Factor (Lef-1) and Msx2 transcription

61 criptional activation of T cell factor (Tcf)/lymphoid-enhancer factor (Lef), and expression of target

62 Wnt/Frizzled-1 signaling to the beta-catenin-lymphoid-enhancer factor (LEF)-T cell factor (Tcf) pathw

63 dence in the distribution of K17 and that of lymphoid-enhancer factor (lef-1), a DNA-bending protein

64 us and form complexes with any member of the lymphoid enhancer factor (LEF1) and T-cell factor (TCF1,

65 nscription factors of multiple T-cell factor/lymphoid enhancer factor regulatory elements, conserved

66 drives beta-catenin to bind to T-cell factor/lymphoid-enhancer factor response elements identified in

67 The T-cell factor/lymphoid enhancer factor sequence was sufficient for rep

68 osphorylation and beta-catenin/T-cell factor/lymphoid enhancer factor signaling leading to MIG-7 upre

69 d, as it induced CD4 mRNA, and T cell factor/lymphoid enhancer factor sites were identified within th

70 ar receptor, androgen receptor (AR), and the Lymphoid Enhancer Factor/T Cell Factor family member, Le

71 Lymphoid enhancer factor/T cell factor proteins (LEF/TCF

72 Lymphoid enhancer factor/T-cell factor (LEF/TCF) are tra

73 e pathway to target genes are members of the lymphoid enhancer factor/T-cell factor (LEF/TCF) family.

74 an evolutionarily conserved binding site for lymphoid enhancer factor/T-cell factor family proteins,

75 Lymphoid enhancer factor/T-cell factor promoter activity

76 vation, as judged by increased activity of a lymphoid enhancer factor/T-cell factor promoter reporter

77 Wnt3a stimulates lymphoid enhancer factor/T-cell factor protein-sensitive

78 cks beta-catenin accumulation, activation of lymphoid enhancer factor/T-cell factor protein-sensitive

79 Confocal fluorescence microscopy and a lymphoid enhancer factor/T-cell factor reporter assay we

80 presence of exogenous Wnt3a, as revealed by lymphoid enhancer factor/T-cell factor/beta-catenin repo

81 criptional coactivator for the T-cell factor/lymphoid enhancer factor (TCF/LEF) family of transcripti

82 sequence-specific DNA-binding T-cell factor/lymphoid enhancer factor (TCF/LEF) family proteins.

83 cers through direct binding to T-cell factor/lymphoid enhancer factor (TCF/LEF) family transcription

84 ased the beta-catenin-mediated T cell factor/lymphoid enhancer factor (TCF/LEF) reporter activity, an

85 slocation and interaction with T-cell factor/lymphoid enhancer factor (TCF/LEF) transcription factors

86 T cell factor/lymphoid enhancer factor (TCF/LEF) transcription factors

87 ssor complex to a Wnt-mediated T-cell factor/lymphoid enhancer factor (TCF/LEF) transcriptional activ

88 er, Wnt3a-induced beta-catenin/T-cell factor/lymphoid enhancer factor (TCF/LEF) transcriptional activ

89 growth factor (EGF) stimulates T-cell factor/lymphoid enhancer factor (Tcf/Lef) transcriptional activ

90 uring liver regeneration using T cell factor/lymphoid enhancer factor (TCF/LEF)-reporter mice (TOPGal

91 The T-cell factor/lymphoid enhancer factor (TCF/LEF; hereafter, TCF) famil

92 nto the nucleus, and activated T cell factor/lymphoid enhancer factor transcription factors.

93 ear stress-induced increase in T-cell factor/lymphoid enhancer factor transcriptional activity was ab

94 774) had elevated constitutive T-cell factor/lymphoid enhancer factor transcriptional activity.

95 ption factor binding sites for T-cell factor/lymphoid enhancer factor were found in the promoter regi